{{Rsnum
|rsid=3792323
|Gene=MAPKAPK3
|Chromosome=3
|position=50622900
|Orientation=plus
|GMAF=0.1387
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=MAPKAPK3
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 50.0 | 34.2 | 15.8
| JPT | 48.8 | 46.3 | 4.9
| YRI | 75.4 | 24.6 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 50.0 | 34.2 | 15.8
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
{{PMID|19208361}} rs3792323 associates with the outcome of IFN therapy in patients with chronic [[hepatitis C]] genotype 1b

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}